Skip to Main Content Menu Search Site

Department: Research and Technology Development

2 Results for 'Research and Technology Development'

  • Technologies (0)
  • Collaborations (0)
  • Team (0)
  • News (0)
  • Pages (0)
  • Multimedia (0)
  • Publications (0)
  • Jobs (2)
  • Events (0)

Jobs 2

  • Research Assistant II – Microbiology and in vivo models
    Research and Technology Development

    We are looking for a motivated Research Assistant II to contribute to a multidisciplinary portfolio of research projects involving procedures of health monitoring, injections, blood sampling, survival surgery, post- operative care, and behavioral studies relating to projects on the ImmunoMaterials Platform.

    Reporting to Staff Scientists on the ImmunoMaterials Platform at the Wyss Institute, you will be responsible for overseeing study animals, daily rounds, and observations to check animal health status; adherence to protocols and techniques at the animal facility; performing and documenting experimental observations in rodent species; and sample processing at the conclusion of the studies. You will also be responsible for maintaining pathogen cultures for in vitro and in vivo experiments. You will run screening assays that are in vitro based, including but not limited to: microbiology, ELISA, enzymatic assays, imaging, and flow cytometry. [001521SR]

    Learn more

  • Scientist I- Brain Targeting Program
    Research and Technology Development

    The Wyss Institute’s Brain Targeting Program (BTP), led by Principal Investigator James Gorman, M.D., Ph.D. and Co-PI Donald Ingber, M.D., Ph.D., is developing brain delivery technologies that enable development of breakthrough brain-targeted therapeutics for diverse brain diseases. Our brain delivery platform enables these therapeutic advances by dramatically improving transport of drugs across the blood-brain barrier (BBB) into the brain. We are looking for a talented scientist to contribute to the development and characterization of our novel antibody brain shuttle compounds and to optimize our shuttles for specific payloads in neurodegenerative diseases. [001369SR]

    Learn more

Close menu